Navigation Links
Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization

Systech Serialized Product Tracking enables expansion of RFID initiative

CRANBURY, N.J., Sept. 10 /PRNewswire/ -- Systech International(TM), a pioneer of Packaging Execution Systems, today announced that its Serialized Product Tracking (SPT) application has been successfully implemented by Purdue Pharma L.P. to provide the key commercial infrastructure needed to expand GEN 2 RFID tagging of OxyContin(R) Tablets. SPT is enabling Purdue to extend the protection of their product while maintaining overall operational efficiency.

Purdue is one of the innovative pharmaceutical companies using Systech SPT software to verify product authenticity throughout the pharmaceutical supply chain.

Purdue leveraged the Systech SPT application in its Wilson, NC facility. Systech SPT appealed to Purdue and their need for an integrated solution to expand the number of product SKU's actively tagged, while ensuring the efficiency of its packaging and shipping operations. The initial project, now a fully operational deployment, provides Purdue with a scalable, sustainable and repeatable infrastructure to address those needs. The infrastructure now in place offers item-level serialization, case aggregation, and an interface to the SAP AII EPCIS.

"The Systech Serialized Product Tracking application provides us with insight into our products and packaging lines from the item level through the case and to our customer orders," said Jeffrey Zerillo, Senior Executive Director, Supply Chain at Purdue. "This increased level of visibility helps to protect the authenticity and integrity of our products in the supply chain. Implementing Systech's Serialized Product Tracking gives us a scalable platform for serialized product tracking that can help us meet regulatory requirements, protect supply chain integrity and maintain vital operational efficiencies."

"We are seeing more and more pharmaceutical companies turn to our serialization products as a means of addressing regulatory compliance and authentication demands," said David DeJean, Director of Sales, Serialization Products, Systech International. "Our software enables the serialization technology that enhances product tracking throughout the supply chain."

About Purdue Pharma L.P.

Purdue Pharma L.P. and its associated companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at

About Systech International

Founded in 1985, Systech International is a global provider of packaging execution systems in the pharmaceutical industry. The powerful combination of Systech's products and services provide companies with complete control over packaging processes along with the actionable intelligence required to continuously improve packaging performance. By partnering with Systech, companies can leverage an agnostic, scaleable architecture, to deliver significant improvements at the machine, line and plant levels. For more information about their company and products, please visit

SOURCE Systech International
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Purdue Pharma Agrees to Pay $600 Million Fine for Misbranding Oxycontin
2. India to benefit from pharma companies move
3. South Africa Wins landmark case against pharmaceutical giants
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
6. Pharma cos must forge Strategic alliances
7. Setting up a new pharmaceutical industry in India
8. Medicis Pharmaceutical company enters pediatric market
9. Supply of Radiopharmaceuticals Hampered by Attacks
10. Pharma majors gear to supply anti-anthrax drug
11. Pharmacies in for a dose of bitter medicine
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... In an ... restrictions and variables that determine which patients are or are not eligible for bariatric ... have a BMI over 40, are more than 100 pounds overweight, or have a ...
(Date:11/24/2015)... UT (PRWEB) , ... November 24, 2015 , ... It ... Magazine. For a business, it is critical that the first impression be positive and ... they are not likely to buy anything or want to return. They will also ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... gather to share their knowledge and experiences at a live taping of the ... Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Aided by ... today announced an innovative study designed to yield insights into how to detect and ... of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic material that ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir Grout of Baltimore is ... certification. The award recognizes good companies for excellence in service and a commitment ... and hard surface restoration company earned this recognition after a thorough review by ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 iRhythm Technologies, ... advancing cardiac care, today announced that it will participate in the ... Hotel in New York, NY . ... present on Tuesday December 1, 2015 at 8:50am ET. ... . --> . ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology: